Multiple sclerosis relapse and Irritable bowel syndrome

Summary:

Irritable bowel syndrome is found among people with Multiple sclerosis relapse, especially for people who are female, 30-39 old.

The study analyzes which people have Irritable bowel syndrome with Multiple sclerosis relapse. It is created by eHealthMe based on reports of 12 people who have Multiple sclerosis relapse from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis relapse?

Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,033 drugs and 943 conditions by eHealthMe. Check the latest studies of Multiple sclerosis relapse.

What is Irritable bowel syndrome?

Irritable bowel syndrome is found to be associated with 1,318 drugs and 2,121 conditions by eHealthMe. Check the latest studies of Irritable bowel syndrome.



On Jul, 13, 2026

12 people who have Multiple Sclerosis Relapse and Irritable Bowel Syndrome are studied.

Would you have Irritable bowel syndrome when you have Multiple sclerosis relapse?

Gender of people who have Multiple Sclerosis Relapse and experienced Irritable Bowel Syndrome *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Multiple Sclerosis Relapse and experienced Irritable Bowel Syndrome *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 75 %
  • 40-49: 25 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 9 people, 75.00%
  2. Progressive Relapsing Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord or both): 9 people, 75.00%
  3. Urination - Excessive At Night: 1 person, 8.33%
  4. Oral Herpes (viral infection of mouth): 1 person, 8.33%
  5. Drowsiness: 1 person, 8.33%

Common drugs taken by these people *:

  1. Vitamin D3: 9 people, 75.00%
  2. Escitalopram: 9 people, 75.00%
  3. Ocrevus: 9 people, 75.00%
  4. Acetaminophen: 6 people, 50.00%
  5. Dimenhydrinate: 6 people, 50.00%
  6. Pregabalin: 6 people, 50.00%
  7. Omeprazole: 6 people, 50.00%
  8. Mcp: 4 people, 33.33%
  9. Albuterol: 4 people, 33.33%
  10. Ibuprofen: 4 people, 33.33%

Common symptoms for these people *:

  1. Fatigue (feeling of tiredness): 10 people, 83.33%
  2. Weakness: 10 people, 83.33%
  3. Nasopharyngitis (inflammation of the nasopharynx): 10 people, 83.33%
  4. Nausea (feeling of having an urge to vomit): 10 people, 83.33%
  5. Dizziness: 10 people, 83.33%
  6. Pain In Extremity: 10 people, 83.33%
  7. White Blood Cell Count Increased: 9 people, 75.00%
  8. Hypersensitivity: 9 people, 75.00%
  9. Head Injury: 9 people, 75.00%
  10. Gait Disturbance: 9 people, 75.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Irritable bowel syndrome?

- Check whether Irritable bowel syndrome is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Irritable bowel syndrome:

All the conditions that are associated with Irritable bowel syndrome:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Irritable bowel syndrome and Multiple sclerosis relapse, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: